- Home
- BMBL vs SLP Comparison
BMBL vs SLP Comparison
Compare BMBL & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMBL | SLP |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | EDP Services |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 405.6M | 326.7M |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | BMBL | SLP |
|---|---|---|
| Price | $3.01 | $18.17 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 6 |
| Target Price | $4.46 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 3.6M | 481.3K |
| Earning Date | 05-05-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.34 | 0.26 |
| Revenue | ★ $965,658,000.00 | $59,577,000.00 |
| Revenue This Year | N/A | $3.80 |
| Revenue Next Year | N/A | $5.90 |
| P/E Ratio | ★ $8.65 | $69.77 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $2.54 | $11.09 |
| 52 Week High | $8.63 | $21.01 |
Technical Indicators
Market Signals| Indicator | BMBL | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 50.94 | 67.04 |
| Support Level | $2.67 | $17.74 |
| Resistance Level | $3.23 | $18.76 |
| Average True Range (ATR) | 0.19 | 0.39 |
| MACD | 0.04 | 0.07 |
| Stochastic Oscillator | 79.53 | 87.35 |
Price Performance
Historical ComparisonAbout BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company operates as one operating segment with revenue derived in the form of recurring subscriptions and in-app purchases. The company operates in USA, which derives maximum revenue; and Rest of the World.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.